GE HealthCare Q4 Revenues $5.7B, EPS $1.44 Tops Estimates
GE HealthCare Technologies delivered Q4 2025 adjusted EPS of $1.44, surpassing consensus by 0.7%, while revenues reached $5.7 billion, 1.9% above estimates. The company holds an estimated long-term earnings growth rate of 9.1%, compared with the industry’s 12.5% forecast.
1. Q4 2025 Earnings Beat Estimates
GE HealthCare Technologies posted adjusted earnings per share of $1.44 in the fourth quarter of fiscal 2025, beating consensus estimates by 0.7%. Revenue for the period reached $5.7 billion, 1.9% above analyst forecasts, driven by strength in key imaging and ultrasound businesses.
2. Growth Outlook and Industry Comparison
The company is projected to achieve a 9.1% compound annual earnings growth rate over the long term, below the industry’s 12.5% forecast. This outlook reflects GE HealthCare’s ongoing focus on operational efficiency and portfolio optimization amid a competitive digital health landscape.